312 related articles for article (PubMed ID: 17394940)
1. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
Halyard MY; Jatoi A; Sloan JA; Bearden JD; Vora SA; Atherton PJ; Perez EA; Soori G; Zalduendo AC; Zhu A; Stella PJ; Loprinzi CL
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1318-22. PubMed ID: 17394940
[TBL] [Abstract][Full Text] [Related]
2. Oral zinc sulfate in the treatment of rosacea: a double-blind, placebo-controlled study.
Sharquie KE; Najim RA; Al-Salman HN
Int J Dermatol; 2006 Jul; 45(7):857-61. PubMed ID: 16863527
[TBL] [Abstract][Full Text] [Related]
3. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
Sangthawan D; Phungrassami T; Sinkitjarurnchai W
J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation.
Ripamonti C; Zecca E; Brunelli C; Fulfaro F; Villa S; Balzarini A; Bombardieri E; De Conno F
Cancer; 1998 May; 82(10):1938-45. PubMed ID: 9587128
[TBL] [Abstract][Full Text] [Related]
8. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study.
Sharquie KE; Najim RA; Al-Dori WS; Al-Hayani RK
J Dermatol; 2006 Aug; 33(8):541-6. PubMed ID: 16923135
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
10. Zinc supplementation and taste in head and neck cancer patients undergoing radiation therapy.
Silverman JE; Weber CW; Silverman S; Coulthard SL; Manning MR
J Oral Med; 1983; 38(1):14-6. PubMed ID: 6573453
[No Abstract] [Full Text] [Related]
11. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study.
Strasser F; Demmer R; Böhme C; Schmitz SF; Thuerlimann B; Cerny T; Gillessen S
Oncologist; 2008 Mar; 13(3):337-46. PubMed ID: 18378545
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
13. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
14. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
[TBL] [Abstract][Full Text] [Related]
16. Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial.
Kazemian A; Kamian S; Aghili M; Hashemi FA; Haddad P
Eur J Cancer Care (Engl); 2009 Mar; 18(2):174-8. PubMed ID: 19267733
[TBL] [Abstract][Full Text] [Related]
17. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
Kozelsky TF; Meyers GE; Sloan JA; Shanahan TG; Dick SJ; Moore RL; Engeler GP; Frank AR; McKone TK; Urias RE; Pilepich MV; Novotny PJ; Martenson JA;
J Clin Oncol; 2003 May; 21(9):1669-74. PubMed ID: 12721240
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
Jahraus CD; Bettenhausen D; Malik U; Sellitti M; St Clair WH
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1483-7. PubMed ID: 16099600
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
20. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).
Bjarnason GA; Mackenzie RG; Nabid A; Hodson ID; El-Sayed S; Grimard L; Brundage M; Wright J; Hay J; Ganguly P; Leong C; Wilson J; Jordan RC; Walker M; Tu D; Parulekar W;
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):166-72. PubMed ID: 18805649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]